Patients with downregulated BACE1-AS expression in ACC, COAD, KIRC, and LIHC had longer overall survival (OS), while the opposite was detected in PAAD and UVM patients (Figure 2(a)). This evidence concerns the gene BACE1 and pancreatic adenocarcinoma.